Most bought healthcare stocks in Q4 2016

See which Healthcare stocks institutional investors increased the most in Q4 2016, measured as net growth in reported share positions from Q3 2016 into Q4 2016. Notable additions at the top of this list include BRISTOL-MYERS SQUIBB CO (BMY), SANOFI-ADR (SNY), WALGREENS BOOTS ALLIANCE INC (WBA), CENCORA INC (COR). These rankings are based on SEC 13F filings from the investors we track.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
BMYBRISTOL-MYERS SQUIBB CO18,710,999$1.25M13309
SNYSANOFI-ADR9,225,910$516.92K01306
WBAWALGREENS BOOTS ALLIANCE INC8,592,458$725.58K12317
CORCENCORA INC6,073,946$470.48K32005
CVSCVS HEALTH CORP5,520,172$359.65K352010
CAHCARDINAL HEALTH INC5,458,547$389.05K41026
GILDGILEAD SCIENCES INC4,891,319$234.27K065012
ALNYALNYLAM PHARMACEUTICALS INC4,052,612-$8.35K11002
BDXBECTON DICKINSON AND CO3,794,191$595.93K32209
MCKMCKESSON CORP2,416,328$243.51K34027
CNCCENTENE CORP2,078,696$108.93K21003
NVSNOVARTIS AG-SPONSORED ADR1,959,449-$379.14K03408
AZNASTRAZENECA PLC-SPONS ADR1,809,757-$239.15K01204
AAGILENT TECHNOLOGIES INC1,776,546$70.25K03004
ELVELEVANCE HEALTH INC1,702,150$457.38K13308
HUMHUMANA INC1,643,912$415.59K03003
ALGNALIGN TECHNOLOGY INC1,599,251$168.55K14005
CYHCOMMUNITY HEALTH SYSTEMS INC1,573,087$6.56K10102
JNJJOHNSON & JOHNSON1,496,691$112.84K089019
XRAYDENTSPLY SIRONA INC1,391,947$77.83K03003
THCTENET HEALTHCARE CORP1,325,875$19.68K10001
ABTABBOTT LABORATORIES1,321,298$18.82K03117
BSXBOSTON SCIENTIFIC CORP1,280,841$22.79K11103
BMRNBIOMARIN PHARMACEUTICAL INC1,004,030$76.54K22004
SYKSTRYKER CORP985,813$146.06K02204
ACHCACADIA HEALTHCARE CO INC970,500$32.12K10001
HOLXHOLOGIC INC833,490$139.60K01203
CORTCORCEPT THERAPEUTICS INC822,500$6.49K01011
REGNREGENERON PHARMACEUTICALS781,230$258.44K31004
CERSCERUS CORP743,815$3.24K20002
TMOTHERMO FISHER SCIENTIFIC INC653,161-$10.79K22309
CARACARA THERAPEUTICS INC640,225$6.18K10011
MCRBSERES THERAPEUTICS INC595,864$5.19K11002
ILMNILLUMINA INC506,078$64.78K20003
WATWATERS CORP493,275-$44.78K04004
HSICHENRY SCHEIN INC485,702$73.67K20003
DVAXDYNAVAX TECHNOLOGIES CORP463,951$1.83K10001
OMIOWENS & MINOR INC387,190$14.19K01001
CRLCHARLES RIVER LABORATORIES384,724$11.81K03003
RHHBYROCHE HOLDINGS LTD-SPONS ADR338,166-$1.69K01001
AMRNAMARIN CORP PLC -ADR335,400$1.03K01001
HALOHALOZYME THERAPEUTICS INC266,834-$13.85K11103
LNTHLANTHEUS HOLDINGS INC238,900$2.10K01001
OSURORASURE TECHNOLOGIES INC225,800$5.20K01001
TFXTELEFLEX INC192,505$29.71K01112
IONSIONIS PHARMACEUTICALS INC181,321$11.75K11002
ACRSACLARIS THERAPEUTICS INC174,600$4.74K10001
INCYINCYTE CORP164,602$20.98K11113
OCULOCULAR THERAPEUTIX INC145,100$1.21K10001
ATECALPHATEC HOLDINGS INC144,300-$58501001
20 symbols with net change in reported shares from tracked managers.0.005.1M10.3M15.4M20.6MNet change in reported shares (tracked managers)BMYSNYWBACORCVSCAHGILDALNYBDXMCKCNCNVSAZNAELVHUMALGNCYHJNJXRAYSymbol

Frequently asked questions about Most bought healthcare stocks in Q4 2016

  • What are the most bought Healthcare stocks in Q4 2016?

    The most bought healthcare stocks in Q4 2016 are those with the largest increase in reported share counts across tracked institutional investors compared to Q3 2016, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors added to the most in Q4 2016?

    Among the managers we track, net additions were largest in companies such as BRISTOL-MYERS SQUIBB CO (BMY), SANOFI-ADR (SNY), WALGREENS BOOTS ALLIANCE INC (WBA), based on aggregated 13F data.

  • How is institutional buying calculated?

    Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q3 2016).

  • Does this include all institutional owners?

    These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.